Longitudinal biomarkers in amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Longitudinal biomarkers in amyotrophic lateral sclerosis

Published:2020-06-09 Issue:7 Volume:7 Page:1103-1116
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Huang Fen¹^ORCID,Zhu Yuda¹,Hsiao‐Nakamoto Jennifer¹,Tang Xinyan¹,Dugas Jason C.¹,Moscovitch‐Lopatin Miriam²,Glass Jonathan D.³,Brown Robert H.⁴,Ladha Shafeeq S.⁵,Lacomis David⁶,Harris Jeffrey M.¹,Scearce‐Levie Kimberly¹,Ho Carole¹,Bowser Robert⁵⁷,Berry James D.²

Affiliation:

1. Denali Therapeutics South San Francisco California USA

2. Sean M. Healey and AMG Center for ALS Massachusetts General Hospital Boston Massachusetts USA

3. Department of Neurology and Pathology Emory University Atlanta Georgia USA

4. Department of Neurology University of Massachusetts Medical School Worcester Massachusetts USA

5. Departments of Neurology and Neurobiology Gregory W. Fulton ALS Center Barrow Neurological Institute Phoenix Arizona USA

6. Live Like Lou Center for ALS Research Department of Neurology University of Pittsburgh Pittsburgh Pennsylvania USA

7. Iron Horse Diagnostics, Inc. Scottsdale Arizona USA

Funder

Denali Therapeutics

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51078

Reference42 articles.

1. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations

2. The phenotypic variability of amyotrophic lateral sclerosis

3. Genetics of amyotrophic lateral sclerosis: A review

4. Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS

5. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis;Brain, Behavior, and Immunity;2024-11

2. Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis;eBioMedicine;2024-10

3. C9orf72repeat expansion-carrying iPSC-microglia from FTD patients show increased phagocytic activity concomitantly with decreased number of autophagosomal-lysosomal vesicles;2024-08-17

4. Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and Analysis;2024-08-13

5. DNL343 is an investigational CNS penetrant eIF2B activator that prevents and reverses the effects of neurodegeneration caused by the Integrated Stress Response;2024-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3